Adicet Bio Inc
XNAS:ACET 4:00:00 PM EDT
| Market Cap (Intraday) | 74.47M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $0.50 |
| 50-Day MA | $0.68 |
| 200-Day MA | $0.71 |
Adicet Bio Inc Stock, XNAS:ACET
131 Dartmouth Street, 3rd floor, Boston, Massachusetts 02116
United States of America
Phone: +1.650.503.9095
Number of Employees: 152
Description
Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of ââ?¬Å?off-the-shelfââ?¬ï¿? gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.


